These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9517860)

  • 1. EEG findings in diabetic patients with and without retinopathy.
    Inui K; Sannan H; Ota H; Uji Y; Nomura S; Kaige H; Kitayama I; Nomura J
    Acta Neurol Scand; 1998 Feb; 97(2):107-9. PubMed ID: 9517860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal slow waves and cerebrovascular diseases.
    Inui K; Motomura E; Kaige H; Nomura S
    Psychiatry Clin Neurosci; 2001 Oct; 55(5):525-31. PubMed ID: 11555350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipole source analysis of temporal slow waves in the elderly.
    Motomura E; Inui K; Ogawa H; Nakase S; Hamanaka K; Honda T; Shiroyama T; Matsumoto T; Komori T; Okada M; Kakigi R
    Neuropsychobiology; 2008; 57(1-2):9-13. PubMed ID: 18424905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG in young diabetics.
    Hauser E; Strohmayer C; Seidl R; Birnbacher R; Lischka A; Schober E
    J Child Neurol; 1995 Jul; 10(4):330-4. PubMed ID: 7594270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
    Sieradzki J
    Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
    Billault BM; Passa PL
    J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the differential diagnosis of cerebral attacks in patients with diabetes mellitus and diabetic syndrome in cerebrovascular disorders in patients without diabetes mellitus].
    Krivoruchko IF
    Probl Endokrinol Gormonoter; 1966; 12(4):36-41. PubMed ID: 6002011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic microangiopathy. Role of capillaroscopy].
    Mouthon JM; Bosquet F; Grimaldi A; Wechsler B; Thervet F; Godeau P
    Presse Med; 1989 Oct; 18(33):1647-50. PubMed ID: 2530551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke topography and outcome in relation to hyperglycaemia and diabetes.
    Kiers L; Davis SM; Larkins R; Hopper J; Tress B; Rossiter SC; Carlin J; Ratnaike S
    J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):263-70. PubMed ID: 1583510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Cystatin C and retinopathy of type-two diabetes mellitus patients.
    Qian C; Wan GM; Yan PS; Wang WZ; Liang SZ; Dong Y
    J Biol Regul Homeost Agents; 2017; 31(1):99-103. PubMed ID: 28337877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of microangiopathy in growth-onset diabetes. With special reference to retinopathy and glycaemic control.
    Sterky G; Wall S
    Acta Paediatr Scand Suppl; 1986; 327():1-45. PubMed ID: 3494378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycosylated hemoglobin as a prognostic index of the appearance of vascular complications in diabetic patients].
    Ezcurra Ferrer EJ; Licea Puig M; Díaz Díaz O
    Rev Clin Esp; 1990; 187(3):121-4. PubMed ID: 2284483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood filterability and hemoglobin-oxygen affinity in diabetic patients with and without retinopathy.
    Martins-Silva J; Levy-Cruz F; Freitas JP; Sousa-Ramalho P
    Acta Diabetol Lat; 1984; 21(2):133-9. PubMed ID: 6475452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between glycohemoglobin, hypoxia parameters and diabetic microangiopathy].
    Gräfenstein K; Duchna W
    Z Gesamte Inn Med; 1985 Apr; 40(8):229-31. PubMed ID: 4013438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic Retinopathy and Neuropathy: New in 2015].
    Henzen C
    Praxis (Bern 1994); 2015 Jun; 104(12):631-4. PubMed ID: 26098239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.